Di Maio, M., G. Daniele, and M.C. Piccirillo. 2013. “Impact on Health-Related Quality of Life of the Addition of Bevacizumab to First-Line Chemotherapy for Ovarian Cancer:  ”. Cancer Breaking News 1 (1):33-35. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254.